PDLIM1 and diffuse large B-cell lymphoma: These findings collectively highlight the importance of PDLIM1 in DLBCL pathogenesis and reveal a novel miR-3940-5p/PDLIM1 regulatory pathway that could potentially be exploited for therapeutic interventions in DLBCL.